Cancer BiologybioRxivPreprint
Concurrent Stereotactic Body Radiation Therapy and KRAS Inhibition Synergistically Improve Pre-clinical Pancreatic Cancer Treatment
Tianyu Wang, Linghua Wang, Jiaqian Xu…·Albert C. Koong
This study shows that combining stereotactic body radiation therapy with KRAS inhibition synergistically improves preclinical pancreatic cancer treatment by enhancing tumor control and reducing recurrence.
DOI 10.64898/2026.07.10.737883